Payment overview · 2025
General Payments
$46.39
2 reported records · 2 companies
Healthcare provider profile · identity verified
Jacob Trombley, DO
Allopathic & Osteopathic Physicians|Family Medicine · ESSEXVILLE, MI · NPI 1750801239
Verified facts
What the public records show
CMS Open Payments records show Jacob Trombley, DO received $46.39 in general payments during 2025 across 2 reported records.
Inspire Medical Systems, Inc. accounted for 57.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $26.55 | 57.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $19.84 | 42.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $46.39 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $26.55 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $19.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 766 | 224 |
| Lisinopril | Lisinopril | 496 | 138 |
| Amlodipine Besylate | Amlodipine Besylate | 419 | 122 |
| Levothyroxine Sodium | Levothyroxine Sodium | 387 | 91 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 377 | 135 |
| Omeprazole | Omeprazole | 281 | 85 |
| Metformin Hcl | Metformin Hcl | 225 | 61 |
| Losartan Potassium | Losartan Potassium | 222 | 68 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 174 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 173 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 157 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 154 | 53 |
| Tamsulosin Hcl | Tamsulosin Hcl | 149 | 56 |
| Meloxicam | Meloxicam | 146 | 55 |
| Fenofibrate | Fenofibrate | 133 | 38 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 129 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 40 |
| Trazodone Hcl | Trazodone Hcl | 128 | 37 |
| Ozempic | Semaglutide | 116 | 27 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 115 | 23 |
| Simvastatin | Simvastatin | 115 | 35 |
| Eliquis | Apixaban | 108 | 33 |
| Furosemide | Furosemide | 105 | 33 |
| Sertraline Hcl | Sertraline Hcl | 104 | 26 |
| Gabapentin | Gabapentin | 99 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 99 | 26 |
| Potassium Chloride | Potassium Chloride | 98 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 95 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 94 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 84 | 24 |
| Finasteride | Finasteride | 82 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 80 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 80 | 25 |
| Alendronate Sodium | Alendronate Sodium | 77 | 25 |
| Carvedilol | Carvedilol | 77 | 23 |
| Buspirone Hcl | Buspirone Hcl | 74 | 19 |
| Famotidine | Famotidine | 72 | 27 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 70 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 65 | 33 |
| Glipizide | Glipizide | 63 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 63 | 15 |
| Atenolol | Atenolol | 62 | 18 |
| Warfarin Sodium | Warfarin Sodium | 62 | 14 |
| Allopurinol | Allopurinol | 61 | 19 |
| Glipizide Er | Glipizide | 59 | 15 |
| Montelukast Sodium | Montelukast Sodium | 53 | 18 |
| Jardiance | Empagliflozin | 50 | 16 |
| Metformin Hcl Er | Metformin Hcl | 50 | 16 |
| Mounjaro | Tirzepatide | 47 | suppressed |
| Ezetimibe | Ezetimibe | 46 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 45 | 12 |
| Ibuprofen | Ibuprofen | 45 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | 13 |
| Synthroid | Levothyroxine Sodium | 41 | 11 |
| Bupropion Xl | Bupropion Hcl | 37 | 14 |
| Baclofen | Baclofen | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Repatha Sureclick | Evolocumab | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 34 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | 14 |
| Donepezil Hcl | Donepezil Hcl | 32 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 32 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 31 | 11 |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | suppressed |
| Trulicity | Dulaglutide | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 27 | 12 |
| Nitroglycerin | Nitroglycerin | 27 | 13 |
| Topiramate | Topiramate | 27 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Pregabalin | Pregabalin | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 15 |
| Prednisone | Prednisone | 19 | 11 |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 14 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Azithromycin | Azithromycin | 11 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Invokana | Canagliflozin | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $46.39 · 2 records | Inspire Medical Systems, Inc. | Cologuard Collection Kit, INSPIRE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error